141 related articles for article (PubMed ID: 2011609)
41. Constriction of cat coronary arteries by synthetic thromboxane A2 and its antagonism.
Smith JB; Yanagisawa A; Zipkin R; Lefer AM
Prostaglandins; 1987 Jun; 33(6):777-82. PubMed ID: 3671730
[TBL] [Abstract][Full Text] [Related]
42. Mediation of bradykinin-induced contraction in canine veins via thromboxane/prostaglandin endoperoxide receptor activation.
Aksoy MO; Harakal C; Smith JB; Stewart GJ; Zerweck CR
Br J Pharmacol; 1990 Mar; 99(3):461-6. PubMed ID: 2110015
[TBL] [Abstract][Full Text] [Related]
43. On the mechanism of prostacyclin and thromboxane A2 biosynthesis.
Hecker M; Ullrich V
J Biol Chem; 1989 Jan; 264(1):141-50. PubMed ID: 2491846
[TBL] [Abstract][Full Text] [Related]
44. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells.
Matsuda K; Mathur RS; Duzic E; Halushka PV
Am J Physiol; 1993 Dec; 265(6 Pt 1):E928-34. PubMed ID: 8279549
[TBL] [Abstract][Full Text] [Related]
45. Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations.
Coleman RA; Humphrey PP; Kennedy I; Levy GP; Lumley P
Br J Pharmacol; 1981 Jul; 73(3):773-8. PubMed ID: 7248665
[TBL] [Abstract][Full Text] [Related]
46. Competitive antagonism at thromboxane receptors in human platelets.
Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
[TBL] [Abstract][Full Text] [Related]
47. Platelet thromboxane A2/endoperoxide (TXA2/PGH2) receptors in type I diabetes mellitus.
Jaschonek K; Faul C; Weisenberger H; Krönert K; Schröder H; Renn W
Thromb Haemost; 1989 Jun; 61(3):535-6. PubMed ID: 2529665
[No Abstract] [Full Text] [Related]
48. Thromboxane A2 analogue U 46619 enhances tumour cell proliferation in HeLa cells via specific receptors which are apparently distinct from TXA2 receptors on human platelets.
Nigam S; Eskafi S; Roscher A; Weitzel H
FEBS Lett; 1993 Jan; 316(1):99-102. PubMed ID: 8422945
[TBL] [Abstract][Full Text] [Related]
49. Prostaglandin endoperoxides modulate the response to thromboxane synthase inhibition during coronary thrombosis.
Fitzgerald DJ; Fragetta J; FitzGerald GA
J Clin Invest; 1988 Nov; 82(5):1708-13. PubMed ID: 3183064
[TBL] [Abstract][Full Text] [Related]
50. Arachidonic acid-induced platelet aggregation is mediated by a thromboxane A2/prostaglandin H2 receptor interaction.
Parise LV; Venton DL; Le Breton GC
J Pharmacol Exp Ther; 1984 Jan; 228(1):240-4. PubMed ID: 6319669
[TBL] [Abstract][Full Text] [Related]
51. Irreversible inhibition of the TXA2/PGH2 receptor of human platelets by a photoaffinity ligand.
Zehender H; Witte EC; Wolff HP; Patscheke H
Biochem Pharmacol; 1988 Feb; 37(3):491-5. PubMed ID: 2962585
[TBL] [Abstract][Full Text] [Related]
52. Binding of thromboxane A2/prostaglandin H2 agonists to human platelets.
Halushka PV; Kochel PJ; Mais DE
Br J Pharmacol; 1987 May; 91(1):223-7. PubMed ID: 3594077
[TBL] [Abstract][Full Text] [Related]
53. Downregulation of nitric oxide accumulation by cyclooxygenase-2 induction and thromboxane A2 production in interleukin-1beta-stimulated rat aortic smooth muscle cells.
Shiokoshi T; Ohsaki Y; Kawabe J; Fujino T; Kikuchi K
J Hypertens; 2002 Mar; 20(3):455-61. PubMed ID: 11875313
[TBL] [Abstract][Full Text] [Related]
54. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
Vezza R; Nenci GG; Gresele P
J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
[TBL] [Abstract][Full Text] [Related]
55. Reversal of thromboxane A2/prostaglandin H2 and ADP-induced calcium release in intact platelets.
Brace LD; Venton DL; Le Breton GC
Am J Physiol; 1985 Jul; 249(1 Pt 2):H8-13. PubMed ID: 2409821
[TBL] [Abstract][Full Text] [Related]
56. Binding characteristics of the new thromboxane A2/prostaglandin H2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes.
Theis JG; Dellweg H; Perzborn E; Gross R
Biochem Pharmacol; 1992 Aug; 44(3):495-503. PubMed ID: 1387312
[TBL] [Abstract][Full Text] [Related]
57. Cultured endothelial cells increase their capacity to synthesize prostacyclin following the formation of a contact inhibited cell monolayer.
Eldor A; Vlodavsky I; Hy-Am E; Atzmon R; Weksler BB; Raz A; Fuks Z
J Cell Physiol; 1983 Feb; 114(2):179-83. PubMed ID: 6401744
[TBL] [Abstract][Full Text] [Related]
58. Prostacyclin and thromboxane A2 synthesis by rabbit pulmonary artery.
Salzman PM; Salmon JA; Moncada S
J Pharmacol Exp Ther; 1980 Oct; 215(1):240-7. PubMed ID: 7005425
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and in vitro pharmacology of 7-oxabicyclo[2.2.1]heptane analogues of thromboxane A2/PGH2.
Sprague PW; Heikes JE; Gougoutas JZ; Malley MF; Harris DN; Greenberg R
J Med Chem; 1985 Nov; 28(11):1580-90. PubMed ID: 4067988
[TBL] [Abstract][Full Text] [Related]
60. Thromboxane A2/prostaglandin H2 receptors in streptozotocin-induced diabetes: effects of insulin therapy in the rat.
Morinelli TA; Tempel GE; Jaffa AA; Silva RH; Naka M; Folger W; Halushka PV
Prostaglandins; 1993 May; 45(5):427-38. PubMed ID: 8321912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
